These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17616680)

  • 1. Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants.
    Bolli N; Nicoletti I; De Marco MF; Bigerna B; Pucciarini A; Mannucci R; Martelli MP; Liso A; Mecucci C; Fabbiano F; Martelli MF; Henderson BR; Falini B
    Cancer Res; 2007 Jul; 67(13):6230-7. PubMed ID: 17616680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal.
    Mariano AR; Colombo E; Luzi L; Martinelli P; Volorio S; Bernard L; Meani N; Bergomas R; Alcalay M; Pelicci PG
    Oncogene; 2006 Jul; 25(31):4376-80. PubMed ID: 16501600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
    Bolli N; De Marco MF; Martelli MP; Bigerna B; Pucciarini A; Rossi R; Mannucci R; Manes N; Pettirossi V; Pileri SA; Nicoletti I; Falini B
    Leukemia; 2009 Mar; 23(3):501-9. PubMed ID: 19005479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML.
    Falini B; Bolli N; Shan J; Martelli MP; Liso A; Pucciarini A; Bigerna B; Pasqualucci L; Mannucci R; Rosati R; Gorello P; Diverio D; Roti G; Tiacci E; Cazzaniga G; Biondi A; Schnittger S; Haferlach T; Hiddemann W; Martelli MF; Gu W; Mecucci C; Nicoletti I
    Blood; 2006 Jun; 107(11):4514-23. PubMed ID: 16455950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
    Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
    Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia-Associated Mutations in Nucleophosmin Alter Recognition by CRM1: Molecular Basis of Aberrant Transport.
    Arregi I; Falces J; Olazabal-Herrero A; Alonso-Mariño M; Taneva SG; Rodríguez JA; Urbaneja MA; Bañuelos S
    PLoS One; 2015; 10(6):e0130610. PubMed ID: 26091065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
    Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
    Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
    Falini B; Mecucci C; Tiacci E; Alcalay M; Rosati R; Pasqualucci L; La Starza R; Diverio D; Colombo E; Santucci A; Bigerna B; Pacini R; Pucciarini A; Liso A; Vignetti M; Fazi P; Meani N; Pettirossi V; Saglio G; Mandelli F; Lo-Coco F; Pelicci PG; Martelli MF;
    N Engl J Med; 2005 Jan; 352(3):254-66. PubMed ID: 15659725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia.
    Falini B; Martelli MP; Bolli N; Bonasso R; Ghia E; Pallotta MT; Diverio D; Nicoletti I; Pacini R; Tabarrini A; Galletti BV; Mannucci R; Roti G; Rosati R; Specchia G; Liso A; Tiacci E; Alcalay M; Luzi L; Volorio S; Bernard L; Guarini A; Amadori S; Mandelli F; Pane F; Lo-Coco F; Saglio G; Pelicci PG; Martelli MF; Mecucci C
    Blood; 2006 Sep; 108(6):1999-2005. PubMed ID: 16720834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nuclear export signal and phosphorylation regulate Dok1 subcellular localization and functions.
    Niu Y; Roy F; Saltel F; Andrieu-Soler C; Dong W; Chantegrel AL; Accardi R; Thépot A; Foiselle N; Tommasino M; Jurdic P; Sylla BS
    Mol Cell Biol; 2006 Jun; 26(11):4288-301. PubMed ID: 16705178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nucleophosmin in acute myeloid leukemia.
    Meani N; Alcalay M
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders.
    Caudill JS; Sternberg AJ; Li CY; Tefferi A; Lasho TL; Steensma DP
    Br J Haematol; 2006 Jun; 133(6):638-41. PubMed ID: 16704439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features.
    Falini B; Nicoletti I; Martelli MF; Mecucci C
    Blood; 2007 Feb; 109(3):874-85. PubMed ID: 17008539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin.
    Quentmeier H; Martelli MP; Dirks WG; Bolli N; Liso A; Macleod RA; Nicoletti I; Mannucci R; Pucciarini A; Bigerna B; Martelli MF; Mecucci C; Drexler HG; Falini B
    Leukemia; 2005 Oct; 19(10):1760-7. PubMed ID: 16079892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
    Falini B
    Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Curious Novel Combination of
    Venanzi A; Rossi R; Martino G; Annibali O; Avvisati G; Mameli MG; Sportoletti P; Tiacci E; Falini B; Martelli MP
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573408
    [No Abstract]   [Full Text] [Related]  

  • 17. Localization of AML-related nucleophosmin mutant depends on its subtype and is highly affected by its interaction with wild-type NPM.
    Brodská B; Kráčmarová M; Holoubek A; Kuželová K
    PLoS One; 2017; 12(4):e0175175. PubMed ID: 28384310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif.
    Falini B; Albiero E; Bolli N; De Marco MF; Madeo D; Martelli M; Nicoletti I; Rodeghiero F
    Leukemia; 2007 Sep; 21(9):2052-4; author reply 2054; discussion 2055-6. PubMed ID: 17637816
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions of the natural product (+)-avrainvillamide with nucleophosmin and exportin-1 Mediate the cellular localization of nucleophosmin and its AML-associated mutants.
    Mukherjee H; Chan KP; Andresen V; Hanley ML; Gjertsen BT; Myers AG
    ACS Chem Biol; 2015 Mar; 10(3):855-63. PubMed ID: 25531824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
    den Besten W; Kuo ML; Williams RT; Sherr CJ
    Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.